Hypercitricemia in Human Cancer
Author Information
Author(s): H. M. Lemon, J. H. Mueller, J. M. Looney, W. H. Chasen, Marcia Kelman
Primary Institution: Boston University School of Medicine
Hypothesis
Is hypercitricemia a common abnormality in untreated advanced cancer patients?
Conclusion
Hypercitricemia is frequently observed in patients with advanced cancer, particularly those with breast, prostate, and lung cancers.
Supporting Evidence
- Hypercitricemia was found in 23.6% of cancer patients studied.
- Women with untreated metastatic breast cancer had significantly higher citrate levels than healthy volunteers.
- Prednisone therapy reduced elevated blood citric acid levels to normal in breast cancer patients.
Takeaway
People with certain types of cancer have higher levels of citric acid in their blood, which might be linked to how their bodies process energy.
Methodology
Citrate concentration in blood was measured using the pentobromoacetone method, with samples taken from patients and healthy volunteers after fasting.
Potential Biases
Potential bias in patient selection and the influence of prior treatments on citrate levels.
Limitations
The study may not account for all variables affecting citrate levels, and the sample may not represent all cancer types.
Participant Demographics
Included 358 individuals: healthy volunteers, patients with benign diseases, and various cancer patients across all stages.
Statistical Information
P-Value
<0.001
Confidence Interval
95%
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website